Recently published research shows promise for a new treatment approach to combat glioblastoma.
New UF-led study in Science Advances offers insights into the likelihood of success of adoptive cellular therapy in certain brain tumor patients
New study led by Dr. Jianping Huang uses novel approach to halt or even shrink late-stage tumors such as glioblastoma, ovarian cancer and pancreatic cancer.
More than 100 brain tumor experts united at the inaugural ReMission Summit in Orlando with a mission to rewrite the story of brain cancer through collaboration and innovation.
Duane Mitchell, M.D., Ph.D., was honored for contributing to the UF Health Cancer Center's national reputation in 2018.